Interim data also suggested a strong trend toward improved PFS and OS when evaluating the STRIDE regimen in combination with TACE vs TACE alone.

AstraZeneca (AZN) announced on Thursday that a combination regimen containing its antitumor agent, Imfinzi, was successful in a late-stage trial for a subset of patients with hepatocellular carcinoma, ...

Please provide your email address to receive an email when new articles are posted on . Transarterial chemoembolization plus vitamin K prolonged progression-free survival compared with TACE alone (262 ...

Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non–Muscle-Invasive Bladder Cancer Progress or Overreach? The following represents disclosure information provided by ...

TRANSARTERIAL CHEMOEMBOLIZATION (TACE) and PERCUTANEOUS ACETIC ACID INJECTION (PAI) are effective treatments for hepatocellular carcinoma (HCC) in the large proportion of patients for whom surgical ...

Giant hepatic hemangiomas present a considerable risk of rupture, particularly in patients with large lesions, thereby posing potential life-threatening consequences. 1 Hence, such patients need ...

OAK BROOK, Ill. – May 23, 2011 – Researchers from China report that in patients with peptic ulcer bleeding in whom endoscopy failed to control the bleeding, transarterial embolization is a safe ...

The latest published report namely Global Transarterial Chemoembolization (TACE) Market Size, Share, Growth, Industry Trends and Forecast to 2028 added by Data Bridge Market Research contains point by ...

Introduction: In patients with inoperable intrahepatic cholangiocarcinoma (ICC), both conventional transarterial chemoembolization (cTACE) and drug-eluting bead TACE (DEB-TACE) can be employed as ...

MOUNTAIN VIEW, CA--(Marketwired - Feb 3, 2015) - Hansen Medical, Inc. (NASDAQ: HNSN) -- An abstract accepted for presentation at the 40th Annual Society of Interventional Radiology (SIR) Meeting ...